Informationssystem  
 
Sie sind hier:» Forschung » Informationssystem » Forschungsbericht » Verbundvorhaben
  • Print this page

Mechanisms of early protective exposures on allergy development

EFRAIM
  EU Cooperation: HEALTH
Sprecher bzw. wiss. Koordinator Prof. Dr. Erika von Mutius
Munich University
Children's Hospital
Lindwurmstrasse 4
80337 München
Telefon: +49 89 5160 7897
Anzahl der Partner14
Marburger Teilnehmer Abteilung für Transfusionsmedizin und Hämostaseologie: Prof. Dr. Harald Renz
Laufzeit und Finanzierung 01.02.2008 - 31.01.2012
4 Jahre
Beschreibung Allergy has developed into a major health concern in Europe. Allergic diseases can currently be managed effectively but not cured. The onset of allergies stars early in life and there is increasing evidence that exogenous factors affecting the incidence of these illnesses exert their effect early in life, in part even prenatally. The highly interdisciplinary EFRAIM project will prospectively investigate the main protective factors in early life influencing the development of allergies in birth cohorts conducted in allergy protective environments in five European countries.

These birth cohorts have been enrolling over 1,000 children and have collected detailed information on the onset of allergic illnesses, objective measures of allergies and a vast amount of information about a number of environmental exposures. Large biobanks with a variety of biological samples have been established. In the EFRAIM project particular attention will be given to the potential role of dietary exposures, lifestyle and other environmental (e.g. microbial) exposures early in life which are causal determinants rather than triggers of the illness.

Externe Teilnehmer
D, Ludwig-Maximilians-Universität München: Prof. Dr. Erika von Mutius
D, Protectimmun GmbH Bochum: Dr. Marion Kauth
IRL, Teagasc - Agriculture and Food Development Authority, Carlow: Dr. Mark Ryan
F, Université de Franche-Comté Besançon: Pauline Fournier
F, Commissariat à l'Énergie Atomique (CEA) Paris: Yves Le Ray
D, Technische Universität München: Ulrike Ronchetti
FIN, Kansanterveyslaitos Helsinki: Jaakko Penttinen
CH, Universität Basel: Prof. Dr. Charlotte Braun-Fahrländer
D, Universität Ulm: Frank Gleixner
CH, Universität Bern: Prof. Dr. Urs Frey
CH, Universität Zürich: Dr. Roger Lauener
NL, Universiteit Utrecht: Monique van der Hoek
A, Kardinal Schwarzenberg'sches Krankenhaus Betriebsgesellschaft mbH Schwarzach: Karl Obermaier

[Länderschlüssel]

Zuletzt aktualisiert: 20.03.2009

 
  Philipps-Universität Marburg

Forschungsbericht der Philipps-Universität Marburg

Impressum